Mike Rossi

Mike Rossi is President and CEO of Y-mAbs Therapeutics and has over 30 years of radiopharma, drug development and commercialization experience. He previously served as President, Medical Group at Mirion Technologies and, before that, was the Head of Radioligand Imaging for Advanced Accelerators Applications (AAA), a Novartis Company. Earlier, he was President of Radiopharma at Jubilant Pharma. He also brings experience from GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International. Mr. Rossi earned a B.S. in Pharmacy from the University of the Sciences in Philadelphia and holds an Authorized Nuclear Pharmacist Certification from Butler University. He has served on several boards of directors and remains a Licensed Pharmacist in the state of Pennsylvania.